Search Results - "SCHUSTER, DAVID M"

Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (18 F) Positron Emission Tomography/Computerized Tomography Imaging in the Staging of Biochemically Recurrent Prostate Cancer by Bach-Gansmo, Tore, Nanni, Cristina, Nieh, Peter T, Zanoni, Lucia, Bogsrud, Tronde Velde, Sletten, Heidi, Korsan, Katrine Andersen, Kieboom, J, Tade, Funmilayo I, Odewole, Oluwaseun, Chau, Albert, Ward, Penelope, Goodman, Mark M, Fanti, Stefano, Schuster, David M, Willoch, Frode

“…Purpose Sensitive detection of cancer foci in men experiencing biochemical recurrence following initial treatment of prostate cancer is of great clinical…”
Get full text

Hyperspectral imaging and quantitative analysis for prostate cancer detection by Akbari, Hamed, Halig, Luma V, Schuster, David M, Osunkoya, Adeboye, Master, Viraj, Nieh, Peter T, Chen, Georgia Z, Fei, Baowei

“…Hyperspectral imaging (HSI) is an emerging modality for various medical applications. Its spectroscopic data might be able to be used to noninvasively detect…”
Get full text

Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques by Santangelo, Philip J, Rogers, Kenneth A, Zurla, Chiara, Blanchard, Emmeline L, Gumber, Sanjeev, Strait, Karen, Connor-Stroud, Fawn, Schuster, David M, Amancha, Praveen K, Hong, Jung Joo, Byrareddy, Siddappa N, Hoxie, James A, Vidakovic, Brani, Ansari, Aftab A, Hunter, Eric, Villinger, Francois

“…ImmunoPET/CT imaging using a labeled SIV-specific antibody can identify sites of viralinfection in SIV-infected macaques without the need for tissue biopsies,…”
Get full text

Imaging of Prostate Cancer Using Fluciclovine by Savir-Baruch, Bital, MD, Zanoni, Lucia, MD, Schuster, David M., MD

“…Prostate cancer is the most common cancer and the second leading cause of cancer death in men in the United States. Despite high prevalence, diagnosis and…”
Get full text

Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach by Squires, Malcolm H., Volkan Adsay, N., Schuster, David M., Russell, Maria C., Cardona, Kenneth, Delman, Keith A., Winer, Joshua H., Altinel, Deniz, Sarmiento, Juan M., El-Rayes, Bassel, Hawk, Natalyn, Staley, Charles A., Maithel, Shishir K., Kooby, David A.

“…Background Clinicians may order Octreoscan or positron emission tomography (PET) scan for staging patients with neuroendocrine tumors (NETs). 111 In-Octreoscan…”
Get full text

A semiautomatic segmentation method for prostate in CT images using local texture classification and statistical shape modeling by Shahedi, Maysam, Halicek, Martin, Guo, Rongrong, Zhang, Guoyi, Schuster, David M., Fei, Baowei

“…Purpose Prostate segmentation in computed tomography (CT) images is useful for treatment planning and procedure guidance such as external beam radiotherapy and…”
Get full text

Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents by McConathy, Jonathan, Yu, Weiping, Jarkas, Nachwa, Seo, Wonewoo, Schuster, David M., Goodman, Mark M.

“…Radiohalogenated α‐amino acids are a diverse and useful class tumor imaging agents suitable for positron emission tomography and single photon emission…”
Get full text

Transport mechanisms of trans -1-amino-3-fluoro[1-14 C]cyclobutanecarboxylic acid in prostate cancer cells by Oka, Shuntaro, Okudaira, Hiroyuki, Yoshida, Yasunori, Schuster, David M, Goodman, Mark M, Shirakami, Yoshifumi

“…Abstract Introduction We investigated the mechanisms of trans -1-amino-3-fluoro[1-14 C]cyclobutanecarboxylic acid ( anti -[14 C]FACBC) transport by…”
Get full text

Comparative evaluation of transport mechanisms of trans -1-amino-3-[18 F]fluorocyclobutanecarboxylic acid and l -[methyl-11 C]methionine in human glioma cell lines by Ono, Masahiro, Oka, Shuntaro, Okudaira, Hiroyuki, Schuster, David M, Goodman, Mark M, Kawai, Keiichi, Shirakami, Yoshifumi

“…Abstract Positron emission tomography (PET) with amino acid tracers is useful for the visualization and assessment of therapeutic effects on gliomas. Our…”
Get full text

Imaging of Prostate Cancer Using Fluciclovine by Savir-Baruch, Bital, MD, Zanoni, Lucia, MD, Schuster, David M., MD

“…Prostate cancer is the most common cancer and the second leading cause of cancer death in men in the United States. Despite high disease prevalence, diagnosis…”
Get full text

Lesion segmentation on 18F-fluciclovine PET/CT images using deep learning by Wang, Tonghe, Lei, Yang, Schreibmann, Eduard, Roper, Justin, Liu, Tian, Schuster, David M., Jani, Ashesh B., Yang, Xiaofeng

“…Background and purpose A novel radiotracer, 18 F-fluciclovine (anti-3- 18 F-FACBC), has been demonstrated to be associated with significantly improved survival…”
Get full text

Aberrant Vascular Anatomy Associated With Artifactual Focal Avidity in the Liver on PSMA PET by Lawal, Ismaheel O., Pectasides, Melina, Parihar, Ashwin Singh, Shah, Hardik U., Halkar, Raghuveer K., Jani, Ashesh B., Schuster, David M.

“…68 Ga-prostate-specific membrane antigen (PSMA) PET/CT is a valuable tool for staging and restaging of prostate cancer. Prostate-specific membrane antigen…”
Get full text

Image Guided Planning for Prostate Carcinomas With Incorporation of Anti-3-[18F]FACBC (Fluciclovine) Positron Emission Tomography: Workflow and Initial Findings From a Randomized Trial by Schreibmann, Eduard, PhD, Schuster, David M., MD, Rossi, Peter J., MD, Shelton, Joseph, MD, Cooper, Sherrie, BA, Jani, Ashesh B., MD, MSEE

“…Purpose18 F-Fluciclovine (anti-1-amino-3-[18 F]fluorocyclobutane-1-carboxylic acid) is a novel positron emission tomography (PET)/computed tomography (CT)…”
Get full text

Amino Acid Metabolism as a Target for Breast Cancer Imaging by Ulaner, Gary A., MD, PhD, Schuster, David M., MD

“…Amino acids are an alternate energy source to glucose, and amino acid metabolism is up-regulated in multiple malignancies, including breast cancers. Multiple…”
Get full text

[18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis by Parent, Ephraim E., Patel, Dhruv, Nye, Jonathon A., Li, Zhuo, Olson, Jeffrey J., Schuster, David M., Goodman, Mark M.

“…Background Stereotactic radiosurgery (SRS) is often the primary treatment modality for patients with intracranial metastatic disease. Despite advances in…”
Get full text

[18F]Fluciclovine PET discrimination between high- and low-grade gliomas by Parent, Ephraim E., Benayoun, Marc, Ibeanu, Ijeoma, Olson, Jeffrey J., Hadjipanayis, Constantinos G., Brat, Daniel J., Adhikarla, Vikram, Nye, Jonathon, Schuster, David M., Goodman, Mark M.

“…Background The ability to accurately and non-invasively distinguish high-grade glioma from low-grade glioma remains a challenge despite advances in molecular…”
Get full text

A Simple Method for Estimating Dose Delivered to Hepatocellular Carcinoma after Yttrium-90 Glass-Based Radioembolization Therapy: Preliminary Results of a Proof of Concept Study by Kokabi, Nima, MD, Galt, James R., PhD, Xing, Minzhi, MD, Camacho, Juan C., MD, Barron, Bruce J., MD, Schuster, David M., MD, Kim, Hyun S., MD

“…Abstract Purpose To investigate a simple semiquantitative method to estimate yttrium-90 (90 Y) dose delivered with radioembolization to infiltrative…”
Get full text

Impact of Clinical Factors on 18F-Flotufolastat Detection Rates in Men With Recurrent Prostate Cancer: Exploratory Analysis of the Phase 3 SPOTLIGHT Study by Lowentritt, Benjamin H., Jani, Ashesh B., Helfand, Brian T., Uchio, Edward M., Morris, Michael A., Michalski, Jeff M., Chau, Albert, Davis, Phillip, Chapin, Brian F., Schuster, David M.

“…18F-Flotufolastat (18F-rhPSMA-7.3) is a newly approved prostate-specific membrane antigen targeting radiopharmaceutical for diagnostic imaging of prostate…”
Get full text

Quantitative Dosimetry for Yttrium-90 Radionuclide Therapy: Tumor Dose Predicts Fluorodeoxyglucose Positron Emission Tomography Response in Hepatic Metastatic Melanoma by Eaton, Bree R., MD, Kim, Hyun S., MD, Schreibmann, Eduard, PhD, Schuster, David M., MD, Galt, James R., PhD, Barron, Bruce, MD, Kim, Sungjin, MS, Liu, Yuan, PhD, Landry, Jerome, MD, Fox, Tim, PhD

“…Abstract Purpose To assess a new method for generating patient-specific volumetric dose calculations and analyze the relationship between tumor dose and…”
Get full text

Update on 18F-Fluciclovine PET for Prostate Cancer Imaging by Parent, Ephraim E, Schuster, David M

“…PET is a functional imaging method that can exploit various aspects of tumor biology to enable greater detection of prostate cancer than can be provided by…”
Get full text